Khan, K. . (2025). Efficacy and safety of sitagliptin, metformin and pioglitazone fixed-dose combination therapy (100 mg/1000mg and 15 mg respectively) as a first-line treatment in obese type 2 diabetes with high insulin resistance. International Journal of Medical and Biomedical Studies, 9(1), 247–251. https://doi.org/10.32553/ijmbs.v9i1.3064